Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $2.64B.
ENTERPRISE VALUE (EV)
$2.64B
AtriCure, Inc.
Market Cap
$2.73B
Enterprise Value (EV)
$2.64B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| AtriCure, Inc. (ATRC) | $2.73B | $2.64B |
| MBX Biosciences, Inc. Common Stock (MBX)vs › | $2.71B | $2.66B |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.70B | $5.10B |
| Precigen, Inc. (PGEN)vs › | $2.69B | $2.77B |
| TransMedics Group, Inc. (TMDX)vs › | $2.77B | $3.17B |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.66B | $4.07B |
| Neogen Corporation (NEOG)vs › | $2.61B | $3.22B |
| NewAmsterdam Pharma Company N.V. (NAMS)vs › | $2.60B | $2.18B |
| Beam Therapeutics Inc. (BEAM)vs › | $2.60B | $2.62B |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.88B | $2.22B |
Market Cap
$2.73B
Total Debt
$76.50M
Cash
$167.43M
Enterprise Value
$2.64B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
